| Project/Area Number |
08670332
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Virology
|
|---|
| Research Institution | Hokkaido University |
|---|
Principal Investigator |
IMAI Shosuke Hokkaido University School of Medicine, Cancer Institute, Department of Virology, Lecturer, 医学部, 講師 (60232592)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
SUGIURA Makoto Hokkaido University School of Medicine, Cancer Institute, Department of Virology, 医学部, 助手 (20241317)
|
|---|
| Project Period (FY) |
1996 – 1997
|
| Project Status |
Completed (Fiscal Year 1997)
|
| Budget Amount *help |
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1997: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1996: ¥1,400,000 (Direct Cost: ¥1,400,000)
|
|---|
| Keywords | Epstein-Barr virus / Tlymphocytes / immortalization / recombinant virus |
|---|
| Research Abstract |
This study aimed to investigate the unclarified Epstein-Barr virus (EBV) activity on normal T-lymphocyte immortalization. For infection experiments, we used recombinant EBV (Akata strain) carrying the neomycin-resistance gene (neo-EBV). Although normal peripheral T lymphocytes could not be infected by neo-EBV,primary thymocytes revealed EBNA1 expression after virus exposure. However, the following selection culture did not yield permanently growing thymocytes infected with neo-EBV even in the presence of interleukin 2 (IL-2) in culture medium, probably because virus-infected thymocytes tended to enter into the virus lytic cycle. These results suggest that EBV infection of thymocytes results in the permissive, not latent, infection in vivo, which may be associated with EBV-induced T-lymphoproliferative disorders.
We are currently studying whether EBNA2, or-3A,or-3C gene can alter EBV-infected T-cell lines, the growth of which is dependent on IL-2 so far, such as in terms of aquisition of IL-2 independency or more malignant phenotype.
|
